Connection
Matthew Greenhawt to Quality-Adjusted Life Years
This is a "connection" page, showing publications Matthew Greenhawt has written about Quality-Adjusted Life Years.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.842 |
|
|
|
-
Greenhawt M, Oppenheimer J, Codispoti CD. A Practical Guide to Understanding Cost-Effectiveness Analyses. J Allergy Clin Immunol Pract. 2021 12; 9(12):4200-4207.
Score: 0.192
-
Sun D, Cafone J, Shaker M, Greenhawt M. The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy. Ann Allergy Asthma Immunol. 2019 12; 123(6):582-589.
Score: 0.166
-
Shaker M, Greenhawt M. Providing cost-effective care for food allergy. Ann Allergy Asthma Immunol. 2019 09; 123(3):240-248.e1.
Score: 0.163
-
Shaker M, Greenhawt M. A primer on cost-effectiveness in the allergy clinic. Ann Allergy Asthma Immunol. 2019 08; 123(2):120-128.e1.
Score: 0.163
-
Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
Score: 0.159